What if, instead of waiting for a donor cornea to become available, you could just print one?
Peter T. Kissinger
Why we need more chemistry in the clinic if we’re to reach the goal of individualized medicine.
New solutions are needed to teach the immune system to recognize biological drugs as partners rather than plunderers.
The promise of genome editing is tempered for genetically heterogeneous diseases – introducing a new approach for rhodopsin-dependent retinitis pigmentosa.
What characteristics make a cancer therapy more likely to effectively treat disease?
How the Maastricht MultiModal Molecular Imaging Institute continues to break new ground in mass spectrometry imaging
Digital technologies could transform healthcare.
Napoleone Ferrara, Distinguished Adjunct Professor of Ophthalmology, UC San Diego School of Medicine, California, USA.
Is gene therapy the answer to an untreatable form of macular degeneration?
There is a shocking lack of attention given to racemization in drug discovery, despite it having huge implications on the efficacy – and safety – of drugs. We hope the tool we have developed will be the first step towards change.
Send me the latest from The Translational Scientist.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.